SEC Form 4 · accession 0001225208-16-028750

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP & Pres, Neuromodulation

Period of report

Feb 27, 2016

Accepted (ET)

Mar 1, 2016 · 4:32 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1,F2	Feb 27, 2016	M	2,389	$0.00	A	173,099	D
Common Stock^F2	Feb 27, 2016	F	1,063	$17.21	D	172,036	D
Common Stock^F1,F2	Feb 28, 2016	M	3,383	$0.00	A	175,419	D
Common Stock^F1,F2	Feb 28, 2016	M	2,270	$0.00	A	177,689	D
Common Stock^F2	Feb 28, 2016	F	2,951	$17.21	D	174,738	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Deferred Stock Units^F1,F3	—	Feb 27, 2016	M	2,389	D	—	Feb 27, 2017	Common Stock	2,389	2,389	D
Deferred Stock Units^F1,F4	—	Feb 28, 2016	M	2,270	D	—	Feb 28, 2016	Common Stock	2,270	0	D
Deferred Stock Units^F1,F5	—	Feb 28, 2016	M	3,383	D	—	Feb 28, 2018	Common Stock	3,383	6,766	D

F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
F5Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.